153 related articles for article (PubMed ID: 18641414)
1. Effects of testosterone on antioxidant systems in male secondary hypogonadism.
Mancini A; Leone E; Festa R; Grande G; Silvestrini A; de Marinis L; Pontecorvi A; Maira G; Littarru GP; Meucci E
J Androl; 2008; 29(6):622-9. PubMed ID: 18641414
[TBL] [Abstract][Full Text] [Related]
2. Hormonal regulation of total antioxidant capacity in seminal plasma.
Mancini A; Festa R; Silvestrini A; Nicolotti N; Di Donna V; La Torre G; Pontecorvi A; Meucci E
J Androl; 2009; 30(5):534-40. PubMed ID: 19234315
[TBL] [Abstract][Full Text] [Related]
3. Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease.
Mancini A; Corbo GM; Gaballo A; Raimondo S; Di Segni C; Gigliotti P; Silvestrini A; Valente S; Littarru GP; Pontecorvi A; Meucci E
Exp Clin Endocrinol Diabetes; 2012 Nov; 120(10):623-8. PubMed ID: 23073919
[TBL] [Abstract][Full Text] [Related]
4. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients.
Cadoni G; Scipione S; Agostino S; Addolorato G; Cianfrone F; Leggio L; Paludetti G; Lippa S
Otol Neurotol; 2007 Oct; 28(7):878-83. PubMed ID: 17558340
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antioxidant systems in pituitary-adrenal axis diseases.
Mancini A; Leone E; Silvestrini A; Festa R; Di Donna V; De Marinis L; Pontecorvi A; Littarru GP; Meucci E
Pituitary; 2010 Jun; 13(2):138-45. PubMed ID: 20012698
[TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia.
Cordero MD; Moreno-Fernández AM; deMiguel M; Bonal P; Campa F; Jiménez-Jiménez LM; Ruiz-Losada A; Sánchez-Domínguez B; Sánchez Alcázar JA; Salviati L; Navas P
Clin Biochem; 2009 May; 42(7-8):732-5. PubMed ID: 19133251
[TBL] [Abstract][Full Text] [Related]
8. Serum oxidizability, total antioxidant status and albumin serum levels in patients with aneurysmal or arterial occlusive disease.
Delimaris I; Georgopoulos S; Kroupis C; Zachari A; Liberi M; Bastounis E; Dionyssiou-Asteriou A
Clin Biochem; 2008 Jun; 41(9):706-11. PubMed ID: 18294962
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in adult growth hormone deficiency: different plasma antioxidant patterns in comparison with metabolic syndrome.
Mancini A; Di Segni C; Bruno C; Olivieri G; Guidi F; Silvestrini A; Meucci E; Orlando P; Silvestri S; Tiano L; Pontecorvi A
Endocrine; 2018 Jan; 59(1):130-136. PubMed ID: 29143180
[TBL] [Abstract][Full Text] [Related]
10. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis.
Ahmadpoor P; Eftekhar E; Nourooz-Zadeh J; Servat H; Makhdoomi K; Ghafari A
Iran J Kidney Dis; 2009 Jan; 3(1):22-7. PubMed ID: 19377255
[TBL] [Abstract][Full Text] [Related]
11. Decreased oxidative stress index of urine in patients with urinary tract infection.
Ciftci H; Verit A; Yeni E; Savas M
Urol Int; 2008; 81(3):312-5. PubMed ID: 18931549
[TBL] [Abstract][Full Text] [Related]
12. Validation of salivary testosterone as a screening test for male hypogonadism.
Morley JE; Perry HM; Patrick P; Dollbaum CM; Kells JM
Aging Male; 2006 Sep; 9(3):165-9. PubMed ID: 17050116
[TBL] [Abstract][Full Text] [Related]
13. Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease.
Mandrioli J; Del Rio D; Zini A; Nichelli P; Merelli E; Beltrami D; Cesari C; Pellegrini N; Brighenti F; Sola P
Neurosci Lett; 2006 Jul; 401(3):203-8. PubMed ID: 16600498
[TBL] [Abstract][Full Text] [Related]
14. The relationship between leptin level and oxidative status parameters in hemodialysis patients.
Horoz M; Aslan M; Koylu AO; Bolukbas C; Bolukbas FF; Selek S; Erel O
Artif Organs; 2009 Jan; 33(1):81-5. PubMed ID: 19178446
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer patients.
Mahdavi R; Faramarzi E; Seyedrezazadeh E; Mohammad-Zadeh M; Pourmoghaddam M
Biol Trace Elem Res; 2009 Jul; 130(1):1-6. PubMed ID: 19148586
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?
Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Sonoda M; Nishizawa H; Iwahashi H; Funahashi T; Nonomura N; Okuyama A
Int J Urol; 2009 Oct; 16(10):830-5. PubMed ID: 19719531
[TBL] [Abstract][Full Text] [Related]
17. Hypogonadotrophic hypogonadism in type 2 diabetes.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
[TBL] [Abstract][Full Text] [Related]
18. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
19. Hypogonadism in male Leprosy patients--a study from rural Uttar pradesh.
Aggrawal K; Madhu SV; Aggrawal K; Kannan AT
J Commun Dis; 2005 Sep; 37(3):219-25. PubMed ID: 17080706
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study.
Schneider HJ; Sievers C; Klotsche J; Böhler S; Pittrow D; Lehnert H; Wittchen HU; Stalla GK
Clin Endocrinol (Oxf); 2009 Mar; 70(3):446-54. PubMed ID: 18691272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
